Targeting the ZNF‐148/miR‐335/SOD2 signaling cascade triggers oxidative stress‐mediated pyroptosis and suppresses breast cancer progression
Cancer Medicine · 2023
DOI: 10.1002/cam4.6673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Yanmei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, First affiliated hospital of Kunming Medical University, Kunming, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Health Training Project of High Level Talents, Kunming Medical University.
Abstract (Originalsprache)
Background
The implication of zinc finger protein 148 (ZNF‐148) in pathophysiology of most human cancers has been reported; however, the biological functions of ZNF‐148 in breast cancer remain unclear. This study sought to elucidate the potential molecular mechanism of ZNF‐148 on breast cancer pathology.
Methods
ZNF148 expression was tested in breast cancer tissues and cells. Then, cells were transfected with ZNF‐148 overexpression or downregulation vector, and the cell proliferation, pyroptosis, apoptosis, and reactive oxygen species (ROS) production were analyzed by MTT, western blot, flow cytometry, and immunofluorescence staining, respectively. Tumor‐bearing nude mouse was used to evaluate tumorigenesis of ZNF‐148. Mechanisms underpinning ZNF‐148 were examined using bioinformatics and luciferase assays.
Results
We found that ZNF‐148 was upregulated in breast cancer tissues and cell lines. Knockdown of ZNF‐148 suppressed malignant phenotypes, including cell proliferation, epithelial‐mesenchymal transition, and tumorigenesis in vitro and in vivo, while ZNF‐148 overexpression had the opposite effects. Further experiments showed that ZNF‐148 deficiency promoted ROS production and triggered both apoptotic and pyroptotic cell death, which were restored by cotreating cells with ROS scavengers. A luciferase reporter assay revealed that miR‐335 was the downstream target of ZNF‐148 and that overexpressed ZNF‐148 increased superoxide dismutase 2 (SOD2) expression by sponging miR‐335. In parallel, both miR‐335 downregulation and SOD2 overexpression abrogated the antitumor effects of ZNF‐148 deficiency on proliferation and pyroptosis in breast cancer cells.
Conclusions
Our findings indicated that ZNF‐148 promotes breast cancer progression by triggering miR‐335/SOD2/ROS‐mediated pyroptotic cell death and aid the identification of potential therapeutic targets for breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, First affiliated hospital of Kunming Medical University, Kunming, People's Republic of China.
- School of Medicine, Yunnan University, Kunming, People's Republic of China.
ORCID-Profile: Yilong Dong
Förderung
- National Natural Science Foundation of China
- Yunnan Health Training Project of High Level Talents
- Kunming Medical University
Zitieren
APA
Wang, Y., Gong, Y., Li, X., Long, W., Zhang, J., Wu, J., & Dong, Y. (2023). Targeting the ZNF‐148/miR‐335/SOD2 signaling cascade triggers oxidative stress‐mediated pyroptosis and suppresses breast cancer progression. Cancer Medicine. https://doi.org/10.1002/cam4.6673
Vancouver
Wang Y, Gong Y, Li X, Long W, Zhang J, Wu J, et al. Targeting the ZNF‐148/miR‐335/SOD2 signaling cascade triggers oxidative stress‐mediated pyroptosis and suppresses breast cancer progression. Cancer Medicine. 2023. doi:10.1002/cam4.6673
BibTeX
@article{Wang2023,
author = {Wang, Yanmei and Gong, Yansi and Li, Xuesha and Long, Weizhao and Zhang, Jiayu and Wu, Jiefang and Dong, Yilong},
title = {Targeting the ZNF‐148/miR‐335/SOD2 signaling cascade triggers oxidative stress‐mediated pyroptosis and suppresses breast cancer progression},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6673}
}
EUVIMED